BioNTech SE - ADR vs Lithium Americas Corp — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Lithium Americas Corp trades at $3.27 (market cap $1.18B). The key difference: BioNTech SE - ADR is far larger — about 19.8× Lithium Americas Corp's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Lithium Americas Corp nearer its low. Which is the better fit depends on your goals.
| BNTX | LAC | |
|---|---|---|
Market Cap | $23.31B | $1.18B |
Sector | Health | Basic Materials |
52-Week High | $119.34 | $10.05 |
52-Week Low | $83.89 | $2.71 |
Enterprise Value | $6.60B | $1.29B |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →